| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |